1 in 10 U.S. adults reported GLP-1 medication use July to August 2025
From July to August 2025, about one in 10 U.S. adults reported taking a glucagon-like peptide-1 receptor agonist (GLP-1 RA) medication during the past year, according to research published in Morbidity and Mortality Weekly Report.
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.